We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Clear all

Refine your search

Content type
Tags
Author

3 results found

Article

King & Wood Mallesons | China | 1 Aug 2016

Highlights on the draft rules of drug registration

On July 25, 2016, the China Food and Drug Administration ("CFDA") published the Administrative Provisions for Drug Registration (Revision) (the

Previous page 1 Next page